Is Boron Bone Turnover Randomized Trial safe?

The current Migaku evidence database contains 1 reusable source document for Boron Bone Turnover Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Results The results showed that MMF exposure significantly improved BMD, bone mineral content (BMC), bone microarchitecture and bone strength in OVX mice. [Wang S (2025); evidence level 2] - For bone turnover, MMF increased the number of osteoblasts on the bone surface of OVX mice as well as the level of serum bone formation marker P1NP, while decreasing the number of osteoclasts and the level of serum bone resorption marker β-CTX. [Wang S (2025); evidence level 2] - The clinical trial's results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels. [Wang S (2025); evidence level 2] - Background Postmenopausal osteoporosis (PMOP) is the most common type of osteoporosis. [Wang S (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.